Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1978 ARTÍCULOS , VIENDO DEL 61 AL 75

Using stable isotope labeling to advance our understanding of Alzheimer's disease etiology and pathology

Hark TJ, Savas JN.

J Neurochem. 2021 Oct;159(2):318-329. doi: 10.1111/jnc.15298. Epub 2021 Feb 2.

Causes and consequences of baseline cerebral blood flow reductions in Alzheimer's disease

Bracko O, Cruz Hernández JC, Park L, Nishimura N, Schaffer CB.

J Cereb Blood Flow Metab. 2021 Jul;41(7):1501-1516. doi: 10.1177/0271678X20982383. Epub 2021 Jan 14.

Nutraceutical based SIRT3 activators as therapeutic targets in Alzheimer's disease

Govindarajulu M, Ramesh S, Neel L, Fabbrini M, Buabeid M, Fujihashi A, Dwyer D, Lynd T, Shah K, Mohanakumar KP, Smith F, Moore T, Dhanasekaran M.

Neurochem Int. 2021 Mar;144:104958. doi: 10.1016/j.neuint.2021.104958. Epub 2021 Jan 12.

Probing Mechanisms and Therapeutic Potential of γ-Secretase in Alzheimer's Disease

Wolfe MS.

Molecules. 2021 Jan 13;26(2):388. doi: 10.3390/molecules26020388.

β-lactam antibiotics to tame down molecular pathways of Alzheimer's disease

Kumari S, Deshmukh R.

Eur J Pharmacol. 2021 Mar 15;895:173877. doi: 10.1016/j.ejphar.2021.173877. Epub 2021 Jan 14.

Improving the Diagnosis of the Frontal Variant of Alzheimer's Disease with the DAPHNE Scale

Lehingue E, Gueniat J, Jourdaa S, Hardouin JB, Pallardy A, Courtemanche H, Rocher L, Etcharry-Bouyx F, Auriacombe S, Mollion H, Formaglio M, Rouaud O, Bretonnière C, Thomas-Antérion C, Boutoleau-Bretonnière C.

J Alzheimers Dis. 2021;79(4):1735-1745. doi: 10.3233/JAD-201088.

Deciphering Alzheimer's Disease Pathogenic Pathway: Role of Chronic Brain Hypoperfusion on p-Tau and mTOR

de la Torre JC.

J Alzheimers Dis. 2021;79(4):1381-1396. doi: 10.3233/JAD-201165.

A Retrospective Study on the Benefits of Combined Citicoline, Memantine, and Acetylcholinesterase Inhibitor Treatments in Older Patients Affected with Alzheimer's Disease

Castagna A, Fabbo A, Manzo C, Lacava R, Ruberto C, Ruotolo G.

J Alzheimers Dis. 2021;79(4):1509-1515. doi: 10.3233/JAD-201211.

Sleep Deprivation, a Link Between Post-Traumatic Stress Disorder and Alzheimer's Disease

Delic V, Ratliff WA, Citron BA.

J Alzheimers Dis. 2021;79(4):1443-1449. doi: 10.3233/JAD-201378.

Therapeutic Strategies Targeting Amyloid-β Receptors and Transporters in Alzheimer's Disease

Lao K, Zhang R, Luan J, Zhang Y, Gou X.

J Alzheimers Dis. 2021;79(4):1429-1442. doi: 10.3233/JAD-200851.

Sexual Dimorphism in the 3xTg-AD Mouse Model and Its Impact on Pre-Clinical Research

Dennison JL, Ricciardi NR, Lohse I, Volmar CH, Wahlestedt C.

J Alzheimers Dis. 2021;80(1):41-52. doi: 10.3233/JAD-201014.

Apoptotic neurons and amyloid-beta clearance by phagocytosis in Alzheimer's disease: Pathological mechanisms and therapeutic outlooks

Tajbakhsh A, Read M, Barreto GE, Ávila-Rodriguez M, Gheibi-Hayat SM, Sahebkar A.

Eur J Pharmacol. 2021 Mar 15;895:173873. doi: 10.1016/j.ejphar.2021.173873. Epub 2021 Jan 16.

Exploring the Anti-Neuroinflammatory Potential of Steroid and Terpenoid-Derived Phytochemicals to Combat Alzheimer's Disease

Kabir MT, Uddin MS, Zaman S, Rahman MS, Behl T, Ahmad A, Hafeez A, Perveen A, Ashraf GM.

Curr Pharm Des. 2021;27(22):2635-2647. doi: 10.2174/1381612826666210101152352.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias